CABALETTA BIO, INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
CABALETTA BIO, INC. (CABA) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $32.56 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-21.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2024-03-21
- CABALETTA BIO, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2022 was $32.56M.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|
| 2022-12-31 | $32.56M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |